東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The role of Growth Associated Protei...

Nemes, Ashley D.

FindBook

Google Book

Amazon

博客來

The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis./
作者:	Nemes, Ashley D.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2016,
面頁冊數:	185 p.
附註:	Source: Dissertation Abstracts International, Volume: 78-02(E), Section: B.
Contained By:	Dissertation Abstracts International78-02B(E).
標題:	Cellular biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10146173
ISBN:	9781369015607

The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis.
Nemes, Ashley D.

The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis. - Ann Arbor : ProQuest Dissertations & Theses, 2016 - 185 p.

Source: Dissertation Abstracts International, Volume: 78-02(E), Section: B.

Thesis (Ph.D.)--Kent State University, 2016.

Epilepsy is the fourth most common neurological disorder in the United States. Although various treatments are available, there is no known cure. Additionally, 30-40% of patients do not respond to currently available antiepileptic therapies. This may be due to our lack of understanding of the underlying mechanisms causing epilepsy and its progression. Through investigating the cellular and molecular changes associated with epilepsy, it is possible to develop new strategies to properly diagnose, treat, monitor progression, and potentially cure epilepsy. Medical intractability within epilepsy is commonly associated with a brain pathology called Cortical Dysplasia (CD), a malformation in the cortex caused by abnormal neurodevelopment. In this work, we show an increased risk of epilepsy in a rat model of CD after traumatic brain injury (TBI) and injection of chemoconvulsant drugs. This result coincides with clinical reports suggesting that CD is an underlying risk factor of chronic epilepsy. It has been shown that Growth Associated Protein 43 (GAP-43), a growth protein that is highly expressed during brain development, is elevated in human CD brain tissue (Ying et al., 2014). In this dissertation, GAP-43 is investigated within CD and normal (non-CD) conditions throughout the course of epilepsy. In parallel to previous findings in human tissue, GAP-43 expression is elevated in CD rat brains, and is increased in response to an insult or an acutely induced seizure.

ISBN: 9781369015607Subjects--Topical Terms:

3172791
Cellular biology.

The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis.
LDR:03281nmm a2200361 4500 001 2153446
005 20171130090821.5
008 190424s2016 ||||||||||||||||| ||eng d
020 $a 9781369015607
035 $a (MiAaPQ)AAI10146173
035 $a AAI10146173
040 $a MiAaPQ $c MiAaPQ
100 1 $a Nemes, Ashley D. $3 3341173
245 1 4 $a The role of Growth Associated Protein 43 (GAP-43) in epileptogenesis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2016
300 $a 185 p.
500 $a Source: Dissertation Abstracts International, Volume: 78-02(E), Section: B.
500 $a Adviser: Imad Najm.
502 $a Thesis (Ph.D.)--Kent State University, 2016.
520 $a Epilepsy is the fourth most common neurological disorder in the United States. Although various treatments are available, there is no known cure. Additionally, 30-40% of patients do not respond to currently available antiepileptic therapies. This may be due to our lack of understanding of the underlying mechanisms causing epilepsy and its progression. Through investigating the cellular and molecular changes associated with epilepsy, it is possible to develop new strategies to properly diagnose, treat, monitor progression, and potentially cure epilepsy. Medical intractability within epilepsy is commonly associated with a brain pathology called Cortical Dysplasia (CD), a malformation in the cortex caused by abnormal neurodevelopment. In this work, we show an increased risk of epilepsy in a rat model of CD after traumatic brain injury (TBI) and injection of chemoconvulsant drugs. This result coincides with clinical reports suggesting that CD is an underlying risk factor of chronic epilepsy. It has been shown that Growth Associated Protein 43 (GAP-43), a growth protein that is highly expressed during brain development, is elevated in human CD brain tissue (Ying et al., 2014). In this dissertation, GAP-43 is investigated within CD and normal (non-CD) conditions throughout the course of epilepsy. In parallel to previous findings in human tissue, GAP-43 expression is elevated in CD rat brains, and is increased in response to an insult or an acutely induced seizure.
520 $a Remarkably, the expression of GAP-43 decreases to baseline levels over time in non-CD brain tissue, but continuously increases in CD brains until spontaneous seizures are observed. Moreover, serum GAP-43 levels are highest in rats that develop spontaneous epilepsy, supporting its use as a biomarker of disease progression. Finally, using a lentiviral vector containing shRNA against GAP-43, we have shown a significant decrease in acutely induced seizure duration and severity, as well as chronic interictal spiking, suggesting inhibition of epileptogenesis.
520 $a Together, these results provide new insight into the important role of GAP-43 within epilepsy and its progression, and advocate it as a novel target protein for diagnosis, treatment and prevention of epileptogenesis within CD.
590 $a School code: 0101.
650 4 $a Cellular biology. $3 3172791
650 4 $a Medicine. $3 641104
650 4 $a Molecular biology. $3 517296
650 4 $a Neurobiology. $3 588707
650 4 $a Biomedical engineering. $3 535387
650 4 $a Neurosciences. $3 588700
690 $a 0379
690 $a 0564
690 $a 0307
690 $a 0421
690 $a 0541
690 $a 0317
710 2 $a Kent State University. $b College of Arts and Sciences / School of Biomedical Sciences. $3 3189614
773 0 $t Dissertation Abstracts International $g 78-02B(E).
790 $a 0101
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10146173